DREQX
Price
$20.19
Change
-$0.05 (-0.25%)
Updated
May 30 closing price
Net Assets
1.56B
GAFFX
Price
$77.00
Change
+$0.03 (+0.04%)
Updated
May 30 closing price
Net Assets
301.73B
Interact to see
Advertisement

DREQX vs GAFFX

Header iconDREQX vs GAFFX Comparison
Open Charts DREQX vs GAFFXBanner chart's image
BNY Mellon Research Growth Z
Price$20.19
Change-$0.05 (-0.25%)
VolumeN/A
Net Assets1.56B
American Funds Growth Fund of Amer F3
Price$77.00
Change+$0.03 (+0.04%)
VolumeN/A
Net Assets301.73B
DREQX vs GAFFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DREQX vs. GAFFX commentary
Jun 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DREQX is a Buy and GAFFX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 302B vs. DREQX (1.56B). GAFFX pays higher dividends than DREQX: GAFFX (0.65) vs DREQX (0.00). DREQX was incepted earlier than GAFFX: DREQX (53 years) vs GAFFX (8 years). DREQX (0.87) is less costly to investors than GAFFX (0.30). DREQX is a more actively managed with annual turnover of: 27.94 vs. GAFFX (25.00). DREQX has a lower initial minimum investment than GAFFX: DREQX (1000) vs GAFFX (1000000). GAFFX annual gain was more profitable for investors over the last year : 9.74 vs. DREQX (4.67). GAFFX return over 5 years is better than : 48.56 vs. DREQX (18.89).
DREQXGAFFXDREQX / GAFFX
Total Expense Ratio0.840.30280%
Annual Report Gross Expense Ratio0.870.30290%
Fund Existence53 years8 years-
Gain YTD-3.2123.397-95%
Front LoadN/AN/A-
Min. Initial Investment100010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.56B302B1%
Annual Yield % from dividends0.000.65-
Returns for 1 year4.679.7448%
Returns for 3 years25.7936.5771%
Returns for 5 years18.8948.5639%
Returns for 10 years35.75N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KTTA0.970.03
+3.19%
Pasithea Therapeutics Corp
BIP33.110.45
+1.38%
Brookfield Infrastructure Partners LP
SMWB7.420.01
+0.13%
Similarweb Ltd
ACRS1.46N/A
N/A
Aclaris Therapeutics
CRNX30.51-0.01
-0.03%
Crinetics Pharmaceuticals